DTIC (Dacarbazin)

DTIC is one of the older chemotherapy drugs which has been around and in use for many years. DTIC is a white powder and when prepared for use, it becomes a clear and colorless liquid and is given by intravenous route only. It is most commonly used in treatment of the following cancers:

• Melanoma

• Soft tissue sarcoma

• Hodgkin's Disease

• Neuroblastoma

The type and extent of a cancer will determine the method and schedule of administration of this drug. This decision is made by the medical oncologist. DTIC is normally given daily for 5-10 days.

Side effects:

The degree and severity of the side effects depend on the amount and schedule of the administration of DTIC. Following are some of the most common and important ill effects:

• Low white blood counts

• Low platelet count

• Anemia

• Hair Loss

• Soreness of the mouth, difficulty swallowing

• Diarrhea

• Transient Liver Damage

It is imperative that patients would relay any side effects or problems to their medical oncologist.